Bioterrorism threats and infectious disease outbreaks are on the rise. Emergent BioSolutions Inc. (EBS) has a stream of revenues from FDA-approved drugs, as well as a full pipeline of drugs under development, to combat these health threats.
{iframe}https://seekingalpha.com/article/4125302-emergent-biosolutions-emerging-biotech{/iframe}